| Literature DB >> 25329982 |
Lisa M Vallely1, Primrose Homiehombo2, Angela Kelly-Hanku3, Antonia Kumbia4, Glen D L Mola5, Andrea Whittaker6.
Abstract
BACKGROUND: In Papua New Guinea abortion is restricted under the Criminal Code Act. While safe abortions should available in certain situations, frequently they are not available to the majority of women. Sepsis from unsafe abortion is a leading cause of maternal mortality. Our findings form part of a wider, mixed methods study designed to identify complications requiring hospital treatment for post abortion care and to explore the circumstances surrounding unsafe abortion.Entities:
Mesh:
Year: 2014 PMID: 25329982 PMCID: PMC4201559 DOI: 10.1371/journal.pone.0110791
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Identification of women admitted following spontaneous and induced abortion.
Social and demographic details : Case Note Review (n = 67).
| All women n = 67 | Induced n = 28 | Spontaneous n = 39 | p-value | ||
|
| 15–24 | 35 (52%) | 20 (71%) | 15 (38%) | p = 0.0078 |
| 25–34 | 26 (39%) | 7 (25%) | 19 (49%) | p = >0.05 | |
| ≥35 | 6 (9%) | 1 (4%) | 5 (13%) | p = >0.05 | |
|
| Married | 49 (73%) | 13 (46%) | 36 (92%) | p = >0.05 |
| Single | 12 (18%) | 11 (39%) | 1 (3%) | p = 0.0001 | |
| Separated | 6 (9%) | 4 (14%) | 2 (5%) | p = >0.05 | |
|
| Eastern Highlands Province | 51 (76%) | 21 (75%) | 30 (77%) | p = >0.05 |
| Other | 15 (22%) | 6 (21%) | 9 (23%) | p = >0.05 | |
| Not Known | 1 (2%) | 1 (4%) | 0 (0%) | p = >0.05 | |
|
| Goroka district | 35 (52%) | 18 (64%) | 17 (44%) | p = >0.05 |
| Other districts in Eastern Highlands | 26 (39%) | 9 (32%) | 17 (44%) | p = >0.05 | |
| Districts outside Eastern Highlands | 6 (9%) | 1 (4%) | 5 (13%) | p = >0.05 | |
|
| University/tertiary | 10 (15%) | 4 (14%) | 6 (15%) | p = >0.05 |
| Grade 11–12 | 6 (9%) | 6 (21%) | 0 (0%) | p = >0.05 | |
| Grade 7–10 | 25 (32%) | 8 (29%) | 17 (44%) | p = >0.05 | |
| Grade 4–6 | 12 (18%) | 6 (21%) | 6 (15%) | p = >0.05 | |
| Grade 1–3 | 9 (13%) | 3 (11%) | 6 (15%) | p = >0.05 | |
| No education | 5 (7%) | 1 (4%) | 4 (10%) | p = >0.05 | |
|
| No paid job | 4 (6%) | 0 (0%) | 4 (10%) | p = >0.05 |
| Subsistence farmer | 26 (39%) | 10 (36%) | 16 (41%) | p = >0.05 | |
| Housewife | 10 (15%) | 3 (11%) | 7 (18%) | p = >0.05 | |
| Teachers | 2 (3%) | 0 (0%) | 2 (5%) | p = >0.05 | |
| Student | 17 (25%) | 12 (43%) | 5 (13%) | p = 0.0053 | |
| Other paid work | 8 (12%) | 3 (11%) | 5 (13%) | p = >0.05 | |
Obstetric History.
| All women | Induced | Spontaneous | p-value | ||
| n = 67 | n = 28 | n = 39 | |||
|
| Nulliparous | 25 (37%) | 13 (46%) | 12 (31%) | p = >0.05 |
| Para 1 | 18 (27%) | 8 (29%) | 10 (26%) | p = >0.05 | |
| Para 2 | 9 (13%) | 3 (11%) | 6 (15%) | p = >0.05 | |
| Para 3 | 9 (13%) | 2 (7%) | 7 (18%) | p = >0.05 | |
| Para 4 | 3 (5%) | 1 (4%) | 2 (5%) | p = >0.05 | |
| Para 5 | 3 (5%) | 1 (4%) | 2 (5%) | p = >0.05 | |
|
| Unplanned/unwanted | 19 (28%) | 18 (64%) | 1 (3%) | p = <0.001 |
| Planned/wanted | 32 (48%) | 3 (11%) | 29 (74%) | p = >0.05 | |
| Unplanned/wanted | 16 (24%) | 7 (25%) | 9 (23%) | p = >0.05 | |
|
| 4–12 weeks | 32 (48%) | 11 (39%) | 21 (54%) | p = >0.05 |
| 13–20 weeks | 32 (48%) | 15 (54%) | 17 (44%) | p = >0.05 | |
| 21–24 weeks | 3 (4%) | 2 (7%) | 1 (3%) | p = >0.05 | |
Clinical presentation.
| All women | Induced | Spontaneous | p-value | ||
| n = 67 | n = 28 | n = 39 | |||
|
| 0–5 days | 47 (70%) | 17 (61%) | 30 (77%) | p = >0.05 |
| 6–10 days | 11 (16%) | 7 (25%) | 4 (10%) | p = >0.05 | |
| 2–4 weeks | 8 (12%) | 4 (14%) | 4 (10%) | p = >0.05 | |
| Not known | 1 (1%) | 0 (0%) | 1 (3%) | p = <0.001 | |
|
| Any pale complexion | 38 (57%) | 15 (54%) | 23 (59%) | p = >0.05 |
| Severe | 5 (13%) | 4 (27%) | 1 (4%) | p = >0.05 | |
| Moderate | 20 (53%) | 7 (47%) | 13 (57%) | p = >0.05 | |
| Mild | 11 (29%) | 4 (26%) | 7 (30%) | p = >0.05 | |
| Not specified | 2 (5%) | 0 (0%) | 2 (9%) | p = >0.05 | |
|
| Just PV bleeding | 10 (15%) | 3 (11%) | 7 (18%) | p = >0.05 |
| PV bleeding, abdominal pain | 41 (61%) | 13 (46%) | 28 (72%) | p = >0.05 | |
| PV bleeding, abdominal pain, fever | 12 (5%) | 10 (36%) | 2 (5%) | p = 0.0013 | |
| Other | 4 (6%) | 2 (7%) | 2 (5%) | p = >0.05 | |
|
| 19 (28%) | 11 (39%) | 8 (21%) | p = >0.05 | |
Duration of hospital stay and management.
| All women | Induced | Spontaneous | p-value | |
| n = 67 | n = 28 | n = 39 | ||
|
| ||||
| 1–2 days | 4 (6%) | 1 (3.5%) | 3 (8%) | P = >0.05 |
| 3–4 days | 41 (61%) | 18 (64%) | 23 (59%) | P = >0.05 |
| 5–6 days | 16 (24%) | 6 (21%) | 10 (26%) | P = >0.05 |
| 7–10 days | 2 (3%) | 1 (3.5%) | 1 (2%) | P = >0.05 |
| >10 days | 4 (6%) | 2 (7%) | 2 (5%) | P = >0.05 |
|
| ||||
| Dilatation and curretage | 63 (94%) | 26 (93%) | 37 (95%) | P = >0.05 |
| Exploratory laparotomy & drainageof pelvic abscess | 2 (3%) | 1 (3.5%) | 1 (2.5%) | P = >0.05 |
| Misoprostol | 1 (1.5%) | 1 (3.5%) | 0 | P = >0.05 |
| Nil treatment | 1 (1.5%) | 0 | 1 (2.5%) | P = >0.05 |
|
| 41 (61%) | 20 (71%) | 21 (54%) | P = >0.05 |
*2 women reporting spontaneous abortion stayed for 12 days; 2 women reporting induced abortion stayed for 20 & 21 days.
Doctor providing management/treatment (NB Only 66/67 women had an intervention).
| All proceduresn = 66 | Dilatation & Curretagen = 63 | Laparotomyn = 2 | Misoprostoln = 1 | |
| Consultant obstetrician | 11 (17%) | 10 (16%) | 1 | 0 |
| Obstetric registrar | 53 (80%) | 51 (81%) | 1 | 1 |
| Resident Medical officer | 2 (3%) | 2 (3%) | 0 | 0 |
Gestation and reported method of abortion.
| All induced abortions n = 28 | Gestation at abortion 7–12 weeks n = 11 | Gestation at abortion 16–24 weeks n = 17 | |
|
| 14 (50%) | 8 (73%) | 6 (35%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6 (22%) | 1 (9%) | 5 (29%) |
|
| 3 (11%) | 1 (9%) | 2 (12%) |
|
| 2 (7%) | - | 2 (12%) |
|
| 1 (3%) | 1 (9%) | - |
|
| 1 (3%) | - | 1 (6%) |
|
| 1 (3%) | - | 1 (6%) |
Recommended guidelines for Misoprostol-only medical abortion [Source: WHO 2012].
| Gestation | Recommended method |
|
| 800 mcg of misoprostol administered vaginally or sublingually. |
|
| Repeat at 3 hourly intervals, but for no longer than 12 hours. |
|
| 400 mcg of misoprostol administered vaginally or sublingually. |
| Repeat at 3 hours for up to five doses. | |
|
| No specific dosing recommendations due to lack of clinical studies. |
| But dose of misoprostol should be reduced, due to the greater sensitivity of the uterus to prostaglandins. |